Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives
US7662823B2 · kind B2 · utility
8Cited by
9References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 15, 2009 |
| Grant date | Feb 16, 2010 |
| Priority date | — |
| Expiry date | Jan 15, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/048
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.